Schizophrenia at a genetics crossroads: Where to now?

Schizophrenia Bulletin

Volumn 39, Issue 3, 2013, Pages 490-495

  Corvin, Aiden ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

biological pathways; network; schizophrenia

Indexed keywords

MICRORNA;

ARTICLE; COMPARATIVE STUDY; EXOME; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; HEREDITY; HUMAN; MUTATION RATE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SCHIZOPHRENIA;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIFACTORIAL INHERITANCE; SCHIZOPHRENIA;

EID: 84876552195     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt041     Document Type: Article

References (61)

1. Sullivan PF. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron. 2010;68:182-186.
2. Owen MJ. Implications of genetic findings for understanding schizophrenia. Schizophr Bull. 2012;38:904-907.
3. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012;13:537-551.
4. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148:1223-1241.
5. Ripke S. XXth World Congress of Psychiatric Genetics; 14-18 October 2012; Hamburg, Germany.
6. Guha S, Rees E, Darvasi A, et al.; for the Molecular Genetics of Schizophrenia Consortium and the Wellcome Trust Case Control Consortium 2. Implication of a Rare Deletion at Distal 16p11.2 in Schizophrenia. JAMA Psychiatry. 2013:1-8.
7. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753.
8. Lee SH, DeCandia TR, Ripke S ; Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ); International Schizophrenia Consortium (ISC); Molecular Genetics of Schizophrenia Collaboration (MGS). Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat Genet. 2012;44:247-250.
9. Kim Y, Zerwas S, Trace SE, Sullivan PF. Schizophrenia genetics: where next? Schizophr Bull. 2011;37:456-463.
10. Morris AP, Voight BF, Teslovich TM, et al.; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulinrelated traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGENT2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981-990.
11. Fromer M, Moran JL, Chambert K, et al. Discovery and statistical genotyping of copy-number variation from wholeexome sequencing depth. Am J Hum Genet. 2012;91:597-607.
12. MacArthur DG, Balasubramanian S, Frankish A, et al.; 1000 Genomes Project Consortium. A systematic survey of lossof-function variants in human protein-coding genes. Science. 2012;335:823-828.
13. Xu B, Roos JL, Dexheimer P, et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet. 2011;43:864-868.
14. Need AC, McEvoy JP, Gennarelli M, et al. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am J Hum Genet. 2012;91:303-312.
15. Xu B, Ionita-Laza I, Roos JL, et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet. 2012;44:1365-1369.
16. Kong A, Frigge ML, Masson G, et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature. 2012;488:471-475.
17. Murphy KC. Schizophrenia and velo-cardio-facial syndrome. Lancet. 2002;359:426-430. (Pubitemid 34158957)
18. Stefansson H, Rujescu D, Cichon S, et al.; GROUP. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455:232-236.
19. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008;455:237-241.
20. Kirov G, Rujescu D, Ingason A, Collier DA, O'Donovan MC, Owen MJ. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull. 2009;35:851-854.
21. Vacic V, McCarthy S, Malhotra D, et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature. 2011;471:499-503.
22. Levinson DF, Duan J, Oh S, et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry. 2011;168:302-316.
23. O'Donovan MC, Craddock N, Norton N, et al.; Molecular Genetics of Schizophrenia Collaboration. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40:1053-1055.
24. Vidal M, Cusick ME, Barabási AL. Interactome networks and human disease. Cell. 2011;144:986-998.
25. Lango AH, Estrara K, Lettre G, et al. Hundreds of variants clustering in genomic loci and biological pathways affect human height. Nature. 2010;467:832-838.
26. Scott RA, Lagou V, Welch RP, et al.; DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44:991-1005.
27. Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell. 2011;147:44-56.
28. Ripke S, Sanders AR, Kendler KS, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011;43:969-976.
29. Purcell SM, Wray NR, et al.; International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460: 748-752.
30. Richards AL, Jones L, Moskvina V, et al.; Molecular Genetics of Schizophrenia Collaboration (MGS); International Schizophrenia Consortium (ISC). Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol Psychiatry. 2012;17:193-201.
31. Camargo LM, Collura V, Rain JC, et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry. 2007;12:74-86. (Pubitemid 44973664)
32. Jia P, Wang L, Fanous AH, Chen X, Kendler KS, Zhao Z; International Schizophrenia Consortium. A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. J Med Genet. 2012;49:96-103.
33. Lips ES, Cornelisse LN, Toonen RF, et al.; International Schizophrenia Consortium. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry. 2012;17:996-1006.
34. O'Dushlaine C, Kenny E, Heron E, et al.; International Schizophrenia Consortium. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry. 2011;16:286-292.
35. Allen Institute for Brain Science. Allen brain atlas. http://www. brain-map.org.
36. Meyer-Lindenberg A, Tost H. Neural mechanisms of social risk for psychiatric disorders. Nat Neurosci. 2012;15: 663-668.
37. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12:56-68.
38. Barabasi AL, Albert R. Emergence of scaling in random networks. Science. 1999;286:509-512.
39. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabási AL. The large-scale organization of metabolic networks. Nature. 2000;407:651-654.
40. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL. The human disease network. Proc Natl Acad Sci USA. 2007;104:8685-8690. (Pubitemid 47175372)
41. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabási AL. Hierarchical organization of modularity in metabolic networks. Science. 2002;297:1551-1555. (Pubitemid 34971002)
42. Enright AJ, Van Dongen S, Ouzounis CA. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 2002;30:1575-1584. (Pubitemid 34679732)
43. Rhissorakrai K, Gunsalus KC. MINE: Module Identification in Networks. BMC Bioinformatics. 2011;12:192. doi:10.1186/1471-2105-12-192.
44. Lim J, Hao T, Shaw C, et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell. 2006;125:801-814. (Pubitemid 43732348)
45. Rossin EJ, Lage K, Raychaudhuri S, et al.; International Inflammatory Bowel Disease Genetics Constortium. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet. 2011;7:e1001273.
46. Gilman SR, Chang J, Xu B, et al. Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat Neurosci. 2012;15:1723-1728.
47. Jia P, Wang L, Fanous AH, Pato CN, Edwards TL, Zhao Z; International Schizophrenia Consortium. Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLoS Comput Biol. 2012;8:e1002587.
48. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474:380-384.
49. Roussos P, Katsel P, Davis KL, Siever LJ, Haroutunian V. A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry. 2012; 69:1205-1213.
50. Lee SA, Tsao TT, Yang KC, et al. Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinformatics. 2011;12 Suppl 13:S20.
51. Haldeman-Englert C, Jewett T. 1q21.1 Microdeletion. In: Pagon RA. Bird TD, Dolan CR, Stephens K and Adam MP, eds. GeneReviews. Seattle, WA: University of Washington; 1993-2011.
52. Splawski I, Timothy KW, Priori SG, et al. Timothy Syndrome. In: Pagon RA. Bird TD, Dolan CR, Stephens K and Adam MP, eds. GeneReviews. Seattle, WA: University of Washington; 1993-2006.
53. Blake DJ, Forrest M, Chapman RM, Tinsley CL, O'Donovan MC, Owen MJ. TCF4, schizophrenia, and Pitt-Hopkins Syndrome. Schizophr Bull. 2010;36:443-447.
54. Das J, Mohammed J, Yu H. Genome-scale analysis of interaction dynamics reveals organization of biological networks. Bioinformatics. 2012;28:1873-1878.
55. Cotsapas C, Voight BF, Rossin E, et al.; FOCiS Network of Consortia. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 2011;7:e1002254.
56. Lichtenstein P, Yip BH, Björk C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234-239.
57. Sullivan PF, Magnusson C, Reichenberg A, et al. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry. 2012;69:1099-1103.
58. Corvin AP. Two patients walk into a clinic.a genomics perspective on the future of schizophrenia. BMC Biol. 2011;9:77.
59. Burne T, Scott E, van Swinderen B, et al. Big ideas for small brains: what can psychiatry learn from worms, flies, bees and fish? Mol Psychiatry. 2011;16:7-16.
60. Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473: 221-225.
61. Nithianantharajah J, Komiyama NH, McKechanie A, et al. Synaptic scaffold evolution generated components of vertebrate cognitive complexity. Nat Neurosci. 2013;16:16-24.